TGThe Guardian·2hHealth
score-0.65
Australia's TGA Acts to Protect Patients on GLP-1 Drugs with Updated Safety Warnings for Rare Eye Disorder
Original
Australian regulator TGA warns of ‘rare but severe’ eye disorder linked to GLP-1 drugs like Ozempic
“Alarming language ('rare but severe,' potential blindness) paired with regulatory warning creates concern, though framed as informational rather than catastrophic.”